These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 18840529

  • 1. -(-)Gossypol promotes the apoptosis of bladder cancer cells in vitro.
    Macoska JA, Adsule S, Tantivejkul K, Wang S, Pienta KJ, Lee CT.
    Pharmacol Res; 2008; 58(5-6):323-31. PubMed ID: 18840529
    [Abstract] [Full Text] [Related]

  • 2. Chemoresistance is associated with increased cytoprotective autophagy and diminished apoptosis in bladder cancer cells treated with the BH3 mimetic (-)-Gossypol (AT-101).
    Mani J, Vallo S, Rakel S, Antonietti P, Gessler F, Blaheta R, Bartsch G, Michaelis M, Cinatl J, Haferkamp A, Kögel D.
    BMC Cancer; 2015 Apr 07; 15():224. PubMed ID: 25885284
    [Abstract] [Full Text] [Related]

  • 3. Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.
    Meng Y, Tang W, Dai Y, Wu X, Liu M, Ji Q, Ji M, Pienta K, Lawrence T, Xu L.
    Mol Cancer Ther; 2008 Jul 07; 7(7):2192-202. PubMed ID: 18645028
    [Abstract] [Full Text] [Related]

  • 4. Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells.
    Li ZM, Jiang WQ, Zhu ZY, Zhu XF, Zhou JM, Liu ZC, Yang DJ, Guang ZZ.
    Cancer Biol Ther; 2008 Jan 07; 7(1):51-60. PubMed ID: 17938578
    [Abstract] [Full Text] [Related]

  • 5. The PPARγ agonist rosiglitazone sensitizes the BH3 mimetic (-)-gossypol to induce apoptosis in cancer cells with high level of Bcl-2.
    Li X, He J, Li B, Gao M, Zeng Y, Lian J, Shi C, Huang Y, He F.
    Mol Carcinog; 2018 Sep 07; 57(9):1213-1222. PubMed ID: 29856104
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression.
    Wong FY, Liem N, Xie C, Yan FL, Wong WC, Wang L, Yong WP.
    PLoS One; 2012 Sep 07; 7(12):e50786. PubMed ID: 23226540
    [Abstract] [Full Text] [Related]

  • 7. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.
    Papadopoulos EI, Yousef GM, Scorilas A.
    Tumour Biol; 2015 May 07; 36(5):3197-207. PubMed ID: 25833690
    [Abstract] [Full Text] [Related]

  • 8. Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer.
    Gazzaniga P, Silvestri I, Gradilone A, Scarpa S, Morrone S, Gandini O, Gianni W, Frati L, Aglianò AM.
    Anticancer Drugs; 2007 Feb 07; 18(2):179-85. PubMed ID: 17159604
    [Abstract] [Full Text] [Related]

  • 9. Functional p53 mutation as a molecular determinant of paclitaxel and gemcitabine susceptibility in human bladder cancer.
    Kielb SJ, Shah NL, Rubin MA, Sanda MG.
    J Urol; 2001 Aug 07; 166(2):482-7. PubMed ID: 11458051
    [Abstract] [Full Text] [Related]

  • 10. BH3 Mimetic ABT-199 Enhances the Sensitivity of Gemcitabine in Pancreatic Cancer in vitro and in vivo.
    Zhou Y, Liu H, Xue R, Tang W, Zhang S.
    Dig Dis Sci; 2018 Dec 07; 63(12):3367-3375. PubMed ID: 30155839
    [Abstract] [Full Text] [Related]

  • 11. A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin.
    Lee EK, Jinesh G G, Laing NM, Choi W, McConkey DJ, Kamat AM.
    Cancer Biol Ther; 2013 Sep 07; 14(9):812-22. PubMed ID: 23792592
    [Abstract] [Full Text] [Related]

  • 12. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG, Yoon CY, Yu JH, Park MJ, Lee JE, Jeong SJ, Hong SK, Byun SS, Lee SE.
    J Urol; 2011 Nov 07; 186(5):2084-93. PubMed ID: 21944112
    [Abstract] [Full Text] [Related]

  • 13. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model.
    McGregor N, Patel L, Craig M, Weidner S, Wang S, Pienta KJ.
    J Cell Biochem; 2010 Aug 01; 110(5):1187-94. PubMed ID: 20589722
    [Abstract] [Full Text] [Related]

  • 14. Chemosensitization of gemcitabine-resistant human bladder cancer cell line both in vitro and in vivo using antisense oligonucleotide targeting the anti-apoptotic gene, clusterin.
    Muramaki M, So A, Hayashi N, Sowery R, Miyake H, Fujisawa M, Gleave ME.
    BJU Int; 2009 Feb 01; 103(3):384-90. PubMed ID: 19007378
    [Abstract] [Full Text] [Related]

  • 15. Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.
    Pinto-Leite R, Arantes-Rodrigues R, Palmeira C, Gaivão I, Cardoso ML, Colaço A, Santos L, Oliveira P.
    J Toxicol Environ Health A; 2012 Feb 01; 75(13-15):788-99. PubMed ID: 22788366
    [Abstract] [Full Text] [Related]

  • 16. Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer.
    Sun M, Zhao W, Xie Q, Zhan Y, Wu B.
    Surg Oncol; 2015 Mar 01; 24(1):28-34. PubMed ID: 25434982
    [Abstract] [Full Text] [Related]

  • 17. Molecular mechanism of phenoxodiol-induced apoptosis in ovarian carcinoma cells.
    Alvero AB, O'Malley D, Brown D, Kelly G, Garg M, Chen W, Rutherford T, Mor G.
    Cancer; 2006 Feb 01; 106(3):599-608. PubMed ID: 16388521
    [Abstract] [Full Text] [Related]

  • 18. Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.
    Yeow WS, Baras A, Chua A, Nguyen DM, Sehgal SS, Schrump DS, Nguyen DM.
    J Thorac Cardiovasc Surg; 2006 Dec 01; 132(6):1356-62. PubMed ID: 17140955
    [Abstract] [Full Text] [Related]

  • 19. Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells.
    Kamat AM, Sethi G, Aggarwal BB.
    Mol Cancer Ther; 2007 Mar 01; 6(3):1022-30. PubMed ID: 17363495
    [Abstract] [Full Text] [Related]

  • 20. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y, Zhang LJ, Bai XG, Xu HJ, Jin ZL, Ding M.
    Biomed Pharmacother; 2018 Oct 01; 106():1307-1316. PubMed ID: 30119201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.